In a survey by the Kaiser Family Foundation, 71% of respondents said they would definitely or probably get inoculated — a significant leap over the 63% who said so in an August/September poll.
States are starting to administer their first doses of Pfizer's newly FDA-authorized COVID-19 vaccine. It marks a new phase in the pandemic, but what's that mean for you?
What can you do when you fear someone you know may be considering suicide? It can feel daunting, but suicide prevention experts say we all can help someone at risk by reaching out and showing we care.
As the first patient to receive an experimental treatment that relied on the gene-editing technique CRISPR continues to do well 17 months later, more patients seem to be benefiting, too.
The power of family history can lead a person to do a lot of things. For Howard Berkes, the family tradition of facing crises head-on led him to sign up for experimental testing of a COVID-19 vaccine.
An administration spokesman said senior government officials would be among the first to get the vaccine, but the president himself later said that White House staff would get it later.
In the U.S., front-line health care workers are likely first in line to get immunized with a COVID-19 vaccine, once the FDA says yes. But what about the rest of us? Here's what we know so far.
A synthetic version of the psychedelic drug ibogaine appears to relieve depression and addiction without producing hallucinations or other dangerous side effects — at least in rodents.
This week’s Medical Minute, discusses efforts to counter the effect of weightlessness on bones and muscle during long space flights such as those planned for Mars.
Pfizer and BioNTech's vaccine is the first to receive an emergency authorization from the Food and Drug Administration. Officials say it may be ready for widespread inoculations within days.
Airlines will play a critical role in transporting COVID-19 vaccines. But there are huge logistical challenges in shipping vaccines quickly and efficiently at low temperatures.
NPR's Ari Shapiro talks with Dr. Jeff Bahr, who oversees medical group operations at Advocate Aurora Health Care in Wisconsin, about challenges the U.S. may face in the COVID-19 vaccine distribution.
Pfizer's COVID-19 vaccine may have side effects that can sometimes knock people out of work for a day or so. Hospitals are planning vaccine campaigns for their workers to avoid staff shortages.
Latinos and African Americans are among those most likely to express skepticism about the coronavirus vaccine. Efforts are underway to change their minds.
A Pfizer board member says the government declined to buy more doses beyond the initial 100 million already agreed upon. Demand from other countries could complicate future purchases.
